Publication | Closed Access

Influence of daily dosage and frequency of administration of rifampicin–levofloxacin therapy on tolerance and effectiveness in 154 patients treated for prosthetic joint infections

Rifampicin–levofloxacin TherapyAntimicrobial SusceptibilityAntibioticsHealthcare-associated InfectionAntimicrobial ResistancePharmacotherapyAntimicrobial ChemotherapyAntimicrobial PharmacokineticsInfection ControlAntimicrobial PharmacodynamicsDaily DosageMedicineProsthetic Joint InfectionsOrthopaedic SurgeryDrug Resistance